BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 12710213)

  • 1. Using cancer genomics to guide clinical decisions.
    Burkard ME; Deming DA; Lauring J
    Cancer; 2017 Apr; 123(8):1288-1291. PubMed ID: 28253425
    [No Abstract]   [Full Text] [Related]  

  • 2. Liquid biopsy and NSCLC.
    Trombetta D; Sparaneo A; Fabrizio FP; Muscarella LA
    Lung Cancer Manag; 2016 Jun; 5(2):91-104. PubMed ID: 30643553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive and specific detection of K-ras mutations in colon tumors by short oligonucleotide mass analysis.
    Lleonart ME; Ramón y Cajal S; Groopman JD; Friesen MD
    Nucleic Acids Res; 2004 Mar; 32(5):e53. PubMed ID: 15037663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood oncogene detection in patients with colorectal carcinoma].
    Raedle J; Brieger A; Zeuzem S
    Z Gastroenterol; 1998 Mar; 36(3):257-9. PubMed ID: 9577911
    [No Abstract]   [Full Text] [Related]  

  • 5. Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA.
    Marchese R; Muleti A; Pasqualetti P; Bucci B; Stigliano A; Brunetti E; De Angelis M; Mazzoni G; Tocchi A; Brozzetti S
    Pancreas; 2006 Mar; 32(2):171-7. PubMed ID: 16552337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of methylated circulating DNA in cancer patients' blood.
    Sunami E; Vu AT; Nguyen SL; Hoon DS
    Methods Mol Biol; 2009; 507():349-56. PubMed ID: 18987826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant DNA in plasma of lung cancer patients: potential for monitoring response to therapy.
    Kimura T; Holland WS; Kawaguchi T; Williamson SK; Chansky K; Crowley JJ; Doroshow JH; Lenz HJ; Gandara DR; Gumerlock PH
    Ann N Y Acad Sci; 2004 Jun; 1022():55-60. PubMed ID: 15251940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for isolation and genetic analysis of circulating tumor DNA in patient plasma.
    Kawaguchi T; Holland WS; Gumerlock PH
    Methods Mol Med; 2003; 85():257-62. PubMed ID: 12710213
    [No Abstract]   [Full Text] [Related]  

  • 9. PCR- and RT-PCR-based methods of tumor detection: potential applications and clinical implications.
    Seiden M; Sklar JL
    Important Adv Oncol; 1996; ():191-204. PubMed ID: 8791136
    [No Abstract]   [Full Text] [Related]  

  • 10. [Digital PCR compartmentalization II. Contribution for the quantitative detection of circulating tumor DNA].
    Caen O; Nizard P; Garrigou S; Perez-Toralla K; Zonta E; Laurent-Puig P; Taly V
    Med Sci (Paris); 2015 Feb; 31(2):180-6. PubMed ID: 25744265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The KRAS oncogene: past, present, and future.
    Kranenburg O
    Biochim Biophys Acta; 2005 Nov; 1756(2):81-2. PubMed ID: 16269215
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.